Weight Loss with MELAS Syndrome in South Africa

A mitochondrial disease where broken energy production affects every high-demand organ — the heart, brain, muscles, and pancreas — requiring nutrition that supports mitochondrial function rather than restricting calories

MELAS stands for Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like Episodes. It is one of the most common mitochondrial diseases, caused most frequently (in approximately 80% of cases) by the m.3243A>G point mutation in mitochondrial DNA (mtDNA), which encodes a transfer RNA for leucine (MT-TL1). This mutation impairs mitochondrial protein synthesis, reducing the efficiency of the electron transport chain — the cellular machinery that converts nutrients into ATP (energy).

Because cells that are metabolically most active (neurones, cardiac muscle, skeletal muscle, pancreatic beta cells) depend most heavily on efficient mitochondrial ATP production, MELAS causes its most devastating effects in these tissues. The hallmark clinical features are stroke-like episodes (not caused by vessel occlusion but by energy failure in brain tissue), seizures, lactic acidosis (accumulation of lactate when cells shift to anaerobic metabolism), myopathy (muscle weakness), sensorineural hearing loss, diabetes mellitus, short stature, and cardiomyopathy.

The weight and nutritional picture in MELAS is complex — and very different from typical weight management. This article explains why standard weight loss approaches can be dangerous in MELAS, and what a metabolically appropriate nutritional strategy actually looks like.

Why Weight Management in MELAS Is Different

1. Energy Failure Is the Core Problem — Not Excess Energy

MELAS cells cannot efficiently convert nutrients into ATP. When calorie intake is reduced significantly, or when fasting is prolonged, cells that are already energy-starved are pushed further into crisis. The body responds by ramping up anaerobic glycolysis — generating ATP inefficiently from glucose — producing large amounts of lactate as a byproduct. This drives lactic acidosis, which can cause vomiting, confusion, and in severe cases, life-threatening acidosis requiring emergency treatment.

For this reason, the nutritional goal in MELAS is NOT to create a calorie deficit — it is to optimise energy substrate delivery and support mitochondrial function. Weight loss, if pursued at all, must be extremely gradual (no more than 0.25 kg/week) and only under dietitian supervision.

2. Mitochondrial Diabetes (MIDD)

MELAS-associated diabetes (Maternally Inherited Diabetes and Deafness, MIDD) is caused by progressive loss of pancreatic beta-cell function due to mitochondrial failure in islet cells. It presents like Type 1.5/LADA diabetes — initially insulin-secretion deficient but not autoimmune. Importantly:

• Metformin is CONTRAINDICATED in MELAS diabetes. Metformin inhibits mitochondrial complex I and worsens lactic acidosis — it can cause fatal lactic acidosis in mitochondrial disease. This cannot be overstated.
• Insulin therapy is the preferred treatment for MELAS diabetes
• SGLT2 inhibitors and GLP-1 agonists (like Ozempic) have not been adequately studied in MELAS — discuss carefully with your metabolic team before using
• Blood sugar management through diet follows a low-glycaemic approach — avoiding blood sugar spikes without fasting

3. Lactic Acidosis Triggers

Several common weight-loss interventions are dangerous in MELAS because they increase lactate production:

• Prolonged fasting or intermittent fasting: Forces anaerobic metabolism — raises lactate. Contraindicated.
• Very-low-calorie diets (<1000 kcal/day): Severe restriction increases metabolic stress and lactate.
• Ketogenic / very-low-carbohydrate diets: Controversial in mitochondrial disease. Some patients tolerate modified low-carb approaches, but classic keto (4:1 fat:carbohydrate) can worsen lactic acidosis in MELAS specifically — it reduces glucose availability when glucose may be the preferred fuel for energy-limited neurones. Only attempt under specialist guidance.
• High-intensity exercise: Intense anaerobic exercise floods muscles with lactate, can precipitate lactic acidosis, and in MELAS patients has been associated with triggering stroke-like episodes. Avoid interval training, sprinting, and heavy resistance training to failure.
• Valproic acid (for seizures): This anti-epileptic drug inhibits mitochondrial function and is generally contraindicated in MELAS. If prescribed, ensure your neurologist is aware of the MELAS diagnosis.

4. Muscle Wasting and Myopathy

Mitochondrial myopathy causes progressive muscle weakness and reduced exercise capacity. Muscle mass is often low despite what may appear to be normal or high body weight — a phenomenon called sarcopenic obesity (low muscle, high fat). This means standard BMI and even body weight may underestimate the degree of muscle loss. DXA body composition scans are the preferred assessment tool.

Muscle wasting reduces resting metabolic rate further, meaning patients need fewer calories than expected for their size — making it easier to accumulate fat even at seemingly modest calorie intake.

5. Cardiomyopathy

Hypertrophic cardiomyopathy is present in a significant proportion of MELAS patients and limits aerobic exercise capacity. Cardiology clearance is required before any exercise programme. Moderate-intensity aerobic exercise is generally safe and beneficial if cardiac function is stable — vigorous exercise is not.

Nutritional Strategy for MELAS Patients

The nutritional goals in MELAS are:

1. Maintain adequate energy delivery to prevent metabolic crisis
2. Support mitochondrial function through targeted micronutrient supplementation
3. Manage MELAS diabetes with low-glycaemic eating without fasting
4. Preserve muscle mass with adequate protein
5. Achieve very gradual body fat reduction if clinically indicated, without metabolic stress

Macronutrient Approach

• Carbohydrates — the primary energy substrate: MELAS cells often preferentially use glucose. Carbohydrate restriction is risky. Maintain moderate carbohydrate intake (40-50% of energy) from low-glycaemic sources: oats, legumes, sweet potato, whole grain bread, rooibos-steeped grain porridges. Avoid simple sugars and white refined starches that cause rapid glucose spikes, especially with MELAS diabetes.
• Protein — 1.2-1.5 g/kg/day: Adequate protein supports muscle preservation in myopathy. Sources: eggs, lean chicken, fish, legumes, low-fat dairy (maas/amasi is an excellent South African fermented dairy option), tofu.
• Fat — 30-35% of energy, emphasis on unsaturated: Olive oil, avocado, nuts, oily fish. Limit saturated fat from fatty meats and full-cream dairy. Avoid trans-fats entirely. Moderate fat intake is preferable to high fat in MELAS.
• Never skip meals: Regular eating every 3-4 hours prevents energy dips and reduces lactic acidosis risk. Three moderate meals plus 2-3 small snacks works well for most MELAS patients.
• Emergency glucose: MELAS patients should always carry fast-acting carbohydrate (glucose tablets, fruit juice, regular cooldrink) to manage hypoglycaemic episodes from insulin therapy or energy depletion during activity.

Mitochondrial Supplement Stack

Several supplements are commonly used in MELAS to support mitochondrial function. Evidence is largely based on biochemical rationale and small trials rather than large RCTs, but risk-benefit is generally favourable:

All supplementation must be discussed with your metabolic physician. Self-prescribing high-dose supplements without medical oversight is not appropriate in a complex mitochondrial disease.

Safe Exercise in MELAS

Exercise in MELAS must be moderate, consistent, and carefully monitored. The benefits — preserved muscle mass, improved cardiovascular fitness, better insulin sensitivity for MELAS diabetes, and improved psychological wellbeing — are real. The risks — lactic acidosis, triggering stroke-like episodes, cardiac events — are also real.

Carry glucose and a phone during all exercise. Exercise with a companion whenever possible. Stop and rest immediately at any warning sign: unusual muscle fatigue, muscle pain/cramps, nausea, headache, or visual changes — these may signal impending lactic acidosis or stroke-like episode.

If Weight Loss Is Clinically Needed

If a MELAS patient has developed genuine excess adiposity (for example, from post-stroke disability reducing mobility, or from MELAS diabetes treatment causing weight gain), very gradual weight reduction may be appropriate. Guidelines:

• Maximum deficit: 200-300 kcal/day — no more
• Target rate: 0.25 kg/week or slower
• Never fast: eat every 3-4 hours
• Monitor lactate: your treating team should check blood lactate levels at baseline and periodically during any dietary change
• Increase protein slightly to protect muscle during the reduction phase
• Work with a registered dietitian experienced in metabolic/mitochondrial disease — the standard weight loss dietitian is not equipped for this complexity

Accessing Care in South Africa

MELAS and mitochondrial disease are managed by metabolic physicians and neurologists at tertiary centres. The primary centres are Wits Donald Gordon Medical Centre and Charlotte Maxeke Johannesburg Academic Hospital (Johannesburg), Red Cross War Memorial Children's Hospital and Groote Schuur Hospital (Cape Town), and Steve Biko Academic Hospital (Pretoria). Mitochondrial genetics testing is available through the National Health Laboratory Service (NHLS) at several sites.

The United Mitochondrial Disease Foundation (UMDF) provides patient education resources accessible to South African patients and families online.